Takis Athanasopoulos

Dr Takis Athanasopoulos is interim Head of Gene Therapy at the MHRA with extensive experience across academia, biotech, Pharma industry and regulatory science. He has been director at GSK and VP at VeonGen, spanning CGT industry, translational research and regulatory science roles. His expertise covers viral vectors, advanced therapeutics, AI adoption, manufacturing and standards, with a strong focus on translating innovative gene therapies into patient benefit.